𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dual therapy for chronic hepatitis B virus

✍ Scribed by Hussien Elsiesy; Douglas Dieterich

Book ID
107540477
Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
261 KB
Volume
7
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination therapy for chronic hepatiti
Combination therapy for chronic hepatitis B
✍ R J Fontana; A S Lok πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

ing Phase I and Phase II clinical trials. Other forms of experimental treatment that are being examined in in vitro and Currently, interferon alfa is the only approved treatment animal models include antisense oligonucleotides and supfor chronic hepatitis B virus (HBV) infection. A 3-to 6pressive HB

Foscarnet therapy in chronic hepatitis B
Foscarnet therapy in chronic hepatitis B virus e antigen carriers
✍ V. G. Bain; H. M. Daniels; A. Chanas; G. J. M. Alexander; Dr. Roger Williams πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 343 KB πŸ‘ 2 views

Foscarnet (trisodium phosphonoformate) is a novel antiviral agent that inhibits viral-specific DNA polymerase. In the present study, eight males with chronic HBV carriage (HBeAg and HBV-DNA seropositivity >I2 months) showing chronic persistent hepatitis (CPH) or chronic active hepatitis (CAH) on liv